Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Minocycline
Drug ID BADD_D01470
Description Minocycline was first described in the literacture in 1966.[A190681] It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria.[A190723] Like other semisynthetic tetracyclines, minocycline has modifications to carbons 7-9 on the D ring to generate higher efficacy than previous tetracyclines.[A190723] Minocycline was granted FDA approval on 30 June 1971.[L11695]
Indications and Usage For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniae and for the treatment of asymptomatic carriers of Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code A01AB23; D10AF07; J01AA08
DrugBank ID DB01017
KEGG ID D05045
MeSH ID D008911
PubChem ID 54675783
TTD Drug ID D08LTU
NDC Product Code 42291-591; 42291-589; 69489-201; 72356-101; 49884-512; 72356-103; 63629-2228; 49884-513; 63629-2229; 49884-511
Synonyms Minocycline | Minox 50 | Aknemin | Aknin-Mino | Aknin Mino | Aknosan | Mynocine | Apo-Minocycline | Apo Minocycline | Arestin | Blemix | Cyclomin | Cyclops | Dentomycin | Dynacin | Icht-Oral | Icht Oral | Klinomycin | Lederderm | Mestacine | Minakne | Mino-Wolff | Mino Wolff | Minocin | Minocin MR | Minoclir | Minocycline Hydrochloride | Hydrochloride, Minocycline | Minocycline Monohydrochloride | Monohydrochloride, Minocycline | Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer | Minolis | Minomycin | Minoplus | Minotab | Akamin | Akne-Puren | Akne Puren
Chemical Information
Molecular Formula C23H27N3O7
CAS Registry Number 10118-90-8
SMILES CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2E1P05181Not Available1421660; 3224399; 1814842
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.0020.004660%
Abdominal pain upper07.01.05.003--
Abortion spontaneous18.01.04.0010.010873%Not Available
Acne23.02.01.0010.001812%Not Available
Activated partial thromboplastin time prolonged13.01.02.0010.000518%
Acute febrile neutrophilic dermatosis23.03.03.033; 01.02.01.0060.002071%Not Available
Acute hepatic failure09.01.03.0010.000878%Not Available
Acute respiratory distress syndrome22.01.03.0010.000777%
Acute respiratory failure22.02.06.001; 14.01.04.0040.001036%Not Available
Agranulocytosis01.02.03.0010.000777%Not Available
Alanine aminotransferase increased13.03.01.0030.004660%
Alopecia23.02.02.001--
Anaemia01.03.02.001--
Anal fissure07.03.01.0020.000518%
Anal fistula07.11.05.0020.000518%
Anaphylactic reaction24.06.03.006; 10.01.07.0010.001812%
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Aneurysm24.02.01.0010.000135%Not Available
Angioedema23.04.01.001; 10.01.05.0090.001812%Not Available
Anxiety19.06.02.002--
Aortic aneurysm24.02.03.0010.001294%Not Available
Aortic valve incompetence02.07.03.0010.001294%Not Available
Aphthous ulcer07.05.06.0020.000518%Not Available
Arterial thrombosis24.01.01.0020.000777%Not Available
Arteritis24.05.01.0010.002848%Not Available
Arthralgia15.01.02.0010.017605%
Arthritis15.01.01.0010.002071%
Ascites07.07.01.001; 02.05.04.002; 09.01.05.0030.000777%
Aspartate aminotransferase increased13.03.01.0060.004142%
The 1th Page    1 2 3 4 5    Next   Last    Total 16 Pages